|Articles|November 6, 2020
Assessing Multiple Critical Quality Attributes of Monoclonal Antibody and Comparability Assessments
Author(s)Agilent Technologies, Inc.
Discover how LC–MS peptide mapping can be used to characterize and quantify different monoclonal antibody (mAb) critical quality attributes (CQAs).
Related Content
Trending on LCGC International
1
ASMS 2026 Award Winners Highlight the Future of Mass Spectrometry
2
How AI and Machine Learning Are Reshaping Separations Science at HPLC 2026
3
ASMS 2026: Phantom Metabolites and the Hidden Chemistry of Electrospray Ionization
4
Hyphenated Chromatography Methods: Successes and Remaining Challenges
5